NWBO (OTC)
NORTHWEST BIOTHRPUTCS INC
$0.182500
-0.009500 (-4.95%)
Prev close: $0.192000
Company Information
- Exchange
- OTC Link
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Linda F. Powers
- Asset Type
- otc
- Website
- —
Fundamentals
- Market Cap
- $315.60M
- Employees
- 25
- P/E (TTM)
- -7.19
- P/B (TTM)
- -6.76
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
2
Strong Buy
4
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Dec 2025 (Q4)
|
$0.00 | $0.00 | +0.0000 | +0.00% |
|
Dec 2024 (Q4)
|
$-0.02 | $0.00 | +0.0000 | +0.00% |
|
Mar 2014 (Q1)
|
$-0.88 | $-0.40 | -0.4822 | -121.22% |
|
Dec 2013 (Q4)
|
$-0.40 | $-0.42 | +0.0182 | +4.35% |
Financial Statements
| Revenues | $2.17M |
| Benefits Costs and Expenses | $120.37M |
| Costs And Expenses | $147.30M |
| Operating Expenses | $52.50M |
| Depreciation and Amortization | $2.72M |
| Research and Development | $23.57M |
| Other Operating Expenses | $27.44M |
| Operating Income/Loss | -$50.33M |
| Income/Loss From Continuing Operations After Tax | -$154.71M |
| Income/Loss From Continuing Operations Before Tax | -$118.19M |
| Net Income/Loss | -$154.75M |
| Net Income/Loss Attributable To Noncontrolling Interest | -$117.02M |
| Net Income/Loss Attributable To Parent | -$37.73M |
| Net Income/Loss Available To Common Stockholders, Basic | -$38.88M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $1.15M |
| Preferred Stock Dividends And Other Adjustments | $1.15M |
| Basic Earnings Per Share | -$0.03 |
| Diluted Earnings Per Share | -$0.03 |
| Basic Average Shares | 4,684,006,669 |
| Diluted Average Shares | 4,684,006,669 |
| Assets | $75.94M |
| Current Assets | $2.57M |
| Noncurrent Assets | $73.37M |
| Fixed Assets | $16.48M |
| Intangible Assets | $51.93M |
| Other Non-current Assets | $4.96M |
| Liabilities | $110.72M |
| Current Liabilities | $73.35M |
| Noncurrent Liabilities | $37.37M |
| Long-term Debt | $51.97M |
| Equity | -$45.17M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | -$45.17M |
| Liabilities And Equity | $75.94M |
| Net Cash Flow From Operating Activities | -$48.34M |
| Net Cash Flow From Operating Activities, Continuing | -$48.34M |
| Net Cash Flow From Investing Activities | -$1.75M |
| Net Cash Flow From Investing Activities, Continuing | -$1.75M |
| Net Cash Flow From Financing Activities | $41.73M |
| Net Cash Flow From Financing Activities, Continuing | $41.73M |
| Net Cash Flow | -$8.35M |
| Net Cash Flow, Continuing | -$8.35M |
| Comprehensive Income/Loss | -$37.28M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$37.28M |
| Other Comprehensive Income/Loss | $81.42M |